4786 studies found for:    "Kidney Diseases"
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
2 Completed Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
Conditions: Chronic Kidney Disease;   Chronic Kidney Failure;   End Stage Kidney Disease;   End Stage Renal Disease
Intervention: Drug: N-acetylcysteine
3 Completed
Has Results
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Coronary Artery Calcification;   Vascular Calcification;   Calcification;   Cardiovascular Disease;   Chronic Renal Failure;   Hyperparathyroidism;   Kidney Disease;   Nephrology;   Secondary Hyperparathyroidism
Intervention: Drug: cinacalcet
4 Completed Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
Conditions: Radiocontrast-Induced Nephropathy;   Chronic Kidney Disease;   Diabetes Mellitus
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
5 Withdrawn Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects
Conditions: Chronic Kidney Disease;   Kidney Disease
Interventions: Drug: MK-0677;   Drug: Placebo
6 Terminated
Has Results
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Conditions: Proteinuric Kidney Disease;   Diabetic Nephropathy;   Hypertensive Nephrosclerosis;   IgA Nephropathy;   Focal Segmental Glomerulosclerosis;   Glomerulopathy (Obesity-associated);   Glomerulonephritis, Membranous
Interventions: Drug: Aliskiren;   Drug: Valsartan
7 Completed Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia
Conditions: End Stage Renal Disease;   Chronic Kidney Disease;   Hyperphosphatemic;   Kidney Disease
Interventions: Drug: AMG 223;   Drug: Placebo
8 Completed
Has Results
Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease
Conditions: Diabetes Mellitus;   Chronic Kidney Disease;   Diabetic Kidney Disease
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
9 Active, not recruiting A Study in Patients With Diabetic Kidney Disease
Conditions: Diabetic Kidney Disease;   Diabetic Nephropathy;   Diabetic Glomerulosclerosis
Interventions: Drug: LY2382770;   Drug: Placebo
10 Completed Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: darbepoetin alfa SF
11 Completed Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: RAD001 placebo;   Drug: RAD001
12 Recruiting Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Conditions: Anemia;   Chronic Kidney Disease;   Kidney Disease
Interventions: Drug: darbepoetin alfa QW;   Drug: darbepoetin alfa Q2W
13 Completed START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism
Conditions: Kidney Disease;   Secondary Hyperparathyroidism;   Chronic Kidney Disease
Intervention: Drug: Sensipar
14 Completed Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: Cinacalcet HCl
15 Completed Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: Darbepoetin Alfa
16 Active, not recruiting VA NEPHRON-D: Diabetes iN Nephropathy Study
Conditions: Kidney Disease;   Nephropathy;   Type 2 Diabetes
Interventions: Drug: losartan;   Drug: lisinopril
17 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
18 Completed Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function
Conditions: Mild Nephropathy;   Moderate Nephropathy;   Diabetes Mellitus
Intervention: Drug: Technosphere Inhalation Powder
19 Completed Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate
Conditions: Contrast Induced Nephropathy;   Kidney Diseases
Intervention: Drug: Sodium bicarbonate
20 Completed Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy
Conditions: Contrast Induced Nephropathy;   Kidney Diseases;   Renal Failure;   Adverse Effects
Interventions: Drug: Acetylcysteine;   Drug: Theophylline;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years